HeartSciences shares jump 11.97% after-hours as Ascendiant Capital raises price target to $9.20 with maintained "Buy" rating.

Monday, Dec 22, 2025 7:28 pm ET1min read
HSCS--
HeartSciences (NASDAQ:HSCS) surged 11.97% in after-hours trading following an updated analyst rating from Ascendiant Capital. Analyst Lucas Ward maintained a "Buy" recommendation for the stock while raising the price target from $9.00 to $9.20, reflecting a 2.22% increase in potential upside. The upgraded target, based on the firm's confidence in the company’s outlook, likely spurred investor optimism and post-market buying activity. The move aligns with the analyst’s reinforced positive stance, which directly supports the stock’s upward trajectory.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet